Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children

ClinicalTrials.gov ID: NCT00980005

Public ClinicalTrials.gov record NCT00980005. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 2:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the immunogenicity and safety of GSK Biologicals' investigational vaccine GSK1557482A.

Study identification

NCT ID
NCT00980005
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
2,116 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
3 Years to 17 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 13, 2009 (Type not available)
Primary completion
Mar 2, 2010 (Actual)
Completion
Jun 17, 2010 (Actual)
Last update posted
Sep 21, 2018

2009 – 2010

United States locations

U.S. sites
28
U.S. states
19
U.S. cities
28
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35205 —
GSK Investigational Site Benton Arkansas 72015 —
GSK Investigational Site Huntington Beach California 92647 —
GSK Investigational Site Paramount California 90723 —
GSK Investigational Site West Covina California 91790 —
GSK Investigational Site Marietta Georgia 30062 —
GSK Investigational Site Woodstock Georgia 30189 —
GSK Investigational Site DeKalb Illinois 60115 —
GSK Investigational Site Newton Kansas 67114 —
GSK Investigational Site Wichita Kansas 67207 —
GSK Investigational Site Woburn Massachusetts 01801 —
GSK Investigational Site Stevensville Michigan 49127 —
GSK Investigational Site St Louis Missouri 63141 —
GSK Investigational Site Henderson Nevada 89015 —
GSK Investigational Site Cortland New York 13045 —
GSK Investigational Site Syracuse New York 13210 —
GSK Investigational Site Cary North Carolina 27518 —
GSK Investigational Site Raleigh North Carolina 27609 —
GSK Investigational Site Austintown Ohio 44515 —
GSK Investigational Site Albany Oregon 97322 —
GSK Investigational Site Erie Pennsylvania 16505 —
GSK Investigational Site Hermitage Pennsylvania 16148 —
GSK Investigational Site Charleston South Carolina 29406 —
GSK Investigational Site Austin Texas 78705 —
GSK Investigational Site Houston Texas 77055 —
GSK Investigational Site Orem Utah 84057 —
GSK Investigational Site Provo Utah 84604 —
GSK Investigational Site Burke Virginia 22015 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00980005, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2018 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00980005 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →